Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Dino Mehic, Daniel Kraemmer, Jasmin Sabrina Rast, Silvia Koder, Michelle Fuchs, Helmuth Haslacher, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2023-185843

Published: 2023

Journal Articles

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Meaghan Colling, Florian Posch, Silvia Koder, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2021) 138 (Supplement 1): 290.

https://doi.org/10.1182/blood-2021-148365

Published: 2021

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

Paul Knoebl, MD, Wolfgang R. Sperr, Peter Schellongowski, MD, Thomas Staudinger, MD, Petra Jilma-Stohlawetz, MD, Peter Quehenberger, MD, Silvia Koder, Ing, Cihan Ay, MD, Karoline V. Gleixner, MD

Blood (2018) 132 (Supplement 1): 2476.

https://doi.org/10.1182/blood-2018-99-116973

Published: 2018

Journal Articles

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Jacob H. Rand, MD, Bas de Laat, MDPhD, Silvia Koder, Peter Quehenberger, MD, Cihan Ay, Ingrid Pabinger, MD

Blood (2015) 126 (23): 652.

https://doi.org/10.1182/blood.V126.23.652.652

Published: 2015

Journal Articles

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Wu Xiao-Xuan, PhD, Silvia Koder, Cihan Ay, MD, Jacob H. Rand, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3555.

https://doi.org/10.1182/blood.V126.23.3555.3555

Published: 2015

Journal Articles

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Johanna Gebhart, Florian Posch, Silvia Koder, Thomas Perkmann, Peter Quehenberger, Claudia Zoghlami, Cihan Ay, Ingrid Pabinger

Blood (2015) 125 (22): 3477–3483.

https://doi.org/10.1182/blood-2014-11-611129

Published: 2015

Journal Articles

Association of Elevated Soluble P-Selectin Levels and Fetal Loss in Women with a History of Venous Thromboembolism.

Cihan Ay, Alexandra Kaider, Silvia Koder, Peter Husslein, MD, Ingrid Pabinger

Blood (2008) 112 (11): 1809.

https://doi.org/10.1182/blood.V112.11.1809.1809

Published: 2008

Journal Articles

Monitoring of ADAMTS13 in Patients with Thrombotic Thrombocytopenic Purpura: Prediction of Response to Therapy, Risk of Relapse, and Long- Term Outcome.

Paul Knoebl, Silvia Koder, Peter Schellongowski, Peter Distelmaier, Peter Quehenberger, Ingrid Pabinger, Bernd Jilma, MD

Blood (2008) 112 (11): 2291.

https://doi.org/10.1182/blood.V112.11.2291.2291

Published: 2008

Journal Articles

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

Cihan Ay, Ralph Simanek, Rainer Vormittag, Daniela Dunkler, Guelay Alguel, Silvia Koder, Gabriela Kornek, Christine Marosi, Oswald Wagner, Christoph Zielinski, Ingrid Pabinger

Blood (2008) 112 (7): 2703–2708.

https://doi.org/10.1182/blood-2008-02-142422

Published: 2008

Journal Articles

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Cihan Ay, MD, Ralph Simanek, MD, Rainer Vormittag, MD, Daniela Dunkler, PhD, Guelay Alguel, MD, Silvia Koder, Oswald Wagner, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2007) 110 (11): 701.

https://doi.org/10.1182/blood.V110.11.701.701

Published: 2007

Journal Articles

High Levels of Soluble P-Selectin Are Associated with the Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant.

Cihan Ay, Lea V. Jungbauer, MD, Thomas Sailer, MD, Theres Tengler, Silvia Koder, Alexandra Kaider, Simon Panzer, MD, Peter Quehenberger, MD, Christine Mannhalter, PhD, Ingrid Pabinger, MD

Blood (2006) 108 (11): 384.

https://doi.org/10.1182/blood.V108.11.384.384

Published: 2006

NARROW

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Association of Elevated Soluble P-Selectin Levels and Fetal Loss in Women with a History of Venous Thromboembolism.

Monitoring of ADAMTS13 in Patients with Thrombotic Thrombocytopenic Purpura: Prediction of Response to Therapy, Risk of Relapse, and Long- Term Outcome.

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

High Levels of Soluble P-Selectin Are Associated with the Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only